NRXS
USDNeuraxis Inc. Common Stock
$2.540-0.120 (-4.511%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.660
High
$2.630
Low
$2.520
Volume
0.12M
Company Fundamentals
Market Cap
25.4M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.38M
Exchange
ASE
Currency
USD
52-Week Range
Low $1.33Current $2.540High $6.2
Related News
GlobeNewswire
NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025
CARMEL, Ind., Nov. 04, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE:NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating
View more
GlobeNewswire
NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population
Achieves significant expansion of NeurAxis' total addressable marketClearance now includes patients aged "8 years and older"Expanded age indication will utilize the upcoming January 1st, 2026, Category I CPT code to
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.